FLT4 抗体 (C-Term, Cytoplasmic Domain)
Our Local Distributor
北京 101111
Quick Overview for FLT4 抗体 (C-Term, Cytoplasmic Domain) (ABIN2385250)
抗原
See all FLT4 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term, Cytoplasmic Domain
-
交叉反应
- 小鼠
-
交叉反应 (详细)
- Calculated cross reactivity: Mo
-
产品特性
- VEGFR3 (Vascular Endothelial Growth Factor Receptor 3, VEGFR-3, Fms-like Tyrosine Kinase 4, FLT-4, Tyrosine-protein Kinase Receptor FLT4, FLT4)
-
纯化方法
- Purified by immunoaffinity chromatography.
-
免疫原
- Synthetic peptide corresponding to 20aa near the C-terminal, cytoplasmic domain of mouse VEGFR3, conjugated to KLH. Species Sequence Homology: rat, 85%, human, 73%.
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal working conditions should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Reconstitute with 100 μL sterile PBS.
-
缓冲液
- Supplied as a lyophilized powder from PBS, 0.1 % BSA.
-
储存条件
- -20 °C
-
储存方法
- -20°C
-
-
- FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
-
别名
- VEGFR3
-
途径
- RTK signaling, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
抗原
-